VEENAT 100MG CAPSULE

Discreption Veenat 100mg tablet is a medication containing imatinib, prescribed for the treatment of specific types of cancers. It functions by inhibiting abnormal cell growth, offering therapeutic benefits for conditions such as leukemia and gastrointestinal stromal tumors.

Veenat 100mg Capsule contains Imatinib mesylate, a targeted tyrosine kinase inhibitor primarily used for treating chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GIST). This medication works by blocking abnormal proteins that cause cancer cells to multiply uncontrollably. Common uses include first-line treatment for newly diagnosed chronic-phase CML and management of advanced or blast-crisis CML. Side effects may include nausea, vomiting, muscle cramps, fatigue, and diarrhea, typically managed through dose adjustment or supportive care. Patients should take precautions including regular blood count monitoring, avoiding grapefruit products that interfere with drug metabolism, and reporting any unusual bleeding or severe infections immediately. Alternative substitutes include Gleevec, Glivec, or second-generation TKIs like Dasatinib and Nilotinib for resistant cases. Frequently asked questions cover pregnancy safety (generally avoided), drug interactions with common medications, and expected response timelines (usually 3-6 months for optimal results). Pricing varies by dosage and pharmacy; consult your physician for treatment plans. Schedule laboratory tests monthly during initial therapy and quarterly thereafter. Book doctor consultations for personalized treatment adjustments and comprehensive cancer care management.